Conventional and enantioselective determination of a new blood glucose-lowering agent in biological fluids using liquid-liquid extraction and high-performance liquid chromatography

J Chromatogr. 1993 Jun 23;616(1):129-34. doi: 10.1016/0378-4347(93)80479-n.

Abstract

Two analytical methods are described for the determination of 2-(4-tert.-butylphenoxy)-7-(4-chlorophenyl)heptanoic acid sodium salt (I) in animal models (beagle dog and rat). Method 1 is conventional reversed-phase high-performance liquid chromatography on an octadecylsilane column with an eluent of acetonitrile-0.02 M potassium buffer (pH 3) (65:35, v/v). Method 2 is used for the enantioselective determination of I. This method uses a chiral column (Chiralcel OJ) with an eluent of n-hexane-2-propanol (95:5, v/v) containing 3 ml/l trifluoracetic acid. The analytical procedure has a recovery of more than 90%; within-run precision of less than 5.1%, and between-run precision of less than 4.3%.

MeSH terms

  • Animals
  • Chromatography, High Pressure Liquid
  • Dogs
  • Female
  • Heptanoic Acids / analysis*
  • Heptanoic Acids / blood
  • Heptanoic Acids / urine
  • Hypoglycemic Agents / analysis*
  • Hypoglycemic Agents / blood
  • Hypoglycemic Agents / urine
  • Indicators and Reagents
  • Male
  • Rats
  • Rats, Inbred Lew
  • Reference Standards
  • Spectrophotometry, Ultraviolet
  • Stereoisomerism

Substances

  • Heptanoic Acids
  • Hypoglycemic Agents
  • Indicators and Reagents
  • 2-(4-tert-butylphenoxy)-7-(4-chlorophenyl)heptanoic acid